Skip to main content

Survival After Lung Surgery for Metastatic Renal Cancer

  • Conference paper
Contemporary Research on Renal Cell Carcinoma

Abstract

The lungs are the most frequent metastatic site (75% of all cases) [3, 9] and are typical of renal cancer dissemination along the vena cava. Biologically it makes sense to render the lung free of the tumor to prevent its further spread. Local excision of metastases is an effective form of treatment in patients with underlying renal cell carcinoma if only one distant organ is affected; solitary lung metastases occur in l%–4% of all cases [14].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atzpodien J, Körfer A, Franks CR, Pollwod AH, Kirchner H (1990) Home therapy with rIL2 and IFN-alpha-2b in advanced human malignancies. Lancet 335: 1509–1512

    Article  PubMed  CAS  Google Scholar 

  2. De Forges A, Rey A, Klink M, Ghosn M, Kramar A, Droz JP (1988) Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis. Semin Surg Oncol 4: 149–154

    Article  PubMed  Google Scholar 

  3. De Kernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148–152

    Google Scholar 

  4. Elson PJ, Witte RS, Trump DL (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48: 7310–7313

    PubMed  CAS  Google Scholar 

  5. Jett JR, Hollinger CG, Zinsmeister AR, Pairolero PC (1983) Pulmonary resection of metastatic renal cell carcinoma. Chest 84: 442

    Article  PubMed  CAS  Google Scholar 

  6. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Statistical Assoc 53: 457–481

    Article  Google Scholar 

  7. Khoury S, Saul A (1986) Metastatic renal adenocarcinoma. In: De Kernion JB, Pavone-Maealuso M (eds) Tumors of the kidney. Williams and Wilkins, Baltimore, pp 194–294

    Google Scholar 

  8. Kim B, Louie AC (1992) Surgical resection following interleukin-2-therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 127: 1343–1349

    PubMed  CAS  Google Scholar 

  9. Maldazys JG, De Kernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Urol 136: 376–379

    PubMed  CAS  Google Scholar 

  10. Mc Nichols DW, Segura JW, De Weerd JH (1981) Renal cell carcinoma. Long-term survival and late recurrence. J Urol 126: 17–23

    CAS  Google Scholar 

  11. Middleton RG (1967) Surgery for metastatic renal cell carcinoma. J Urol 97:973–979

    PubMed  CAS  Google Scholar 

  12. Montie JE, Stewart BH, Straffon RA, Banowsky LHW, Hewitt CB, Montague DK (1977) The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol 117: 376–379

    Google Scholar 

  13. Muss HB (1987) Interferon therapy for renal cell carcinoma. Semin Oncol 14: 36–42

    PubMed  CAS  Google Scholar 

  14. O–Dea MJ, Zincke H, Utz DC, Bernatz BE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120: 540–542

    PubMed  Google Scholar 

  15. Palmer PA, Vinke J, Philip T, Negrier S, Atzpodien J, Kirchner H, Oskam R, Franks CR (1992) Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol 3: 475–480

    PubMed  CAS  Google Scholar 

  16. Peto R, Peto J (1972) Asymptomatically efficient rank invariant test procedures. J R Statistical Soc A 135: 185–206

    Article  Google Scholar 

  17. Pomer S, Thiele R, Daniel V, Weimer R, Löhrke H, Schirrmacher V, Staehler G (1991) Sequential treatment of patients with advanced renal cell carcinoma with autologous tumor vaccine and subcutanous administration of recombinant interleukin 2 and interferon alpha-2b. World J Urol 9: 223–227

    Article  Google Scholar 

  18. Rosenberg SA, Lotze MT, Mule J J (1988) New approaches to the immunotherapy of cancer using interleukin-2. Ann Intern Med 108: 853–864

    PubMed  CAS  Google Scholar 

  19. Rosenberg SA, Lotze MT, Yang JC (1989) Combination therapy with IL-2 and IFN-alpha for the treatment of patients with advanced cancer. J Clin Oncol 7: 1726–1732

    Google Scholar 

  20. Vogt-Moykopf I, Meyer G (1986) Surgical technique in operations for pulmonary metastases. J Thorac Cardio vase Surg 34: 125–132

    Article  Google Scholar 

  21. West WH, Tauer KN, Yannelli JR (1987) Constant-infusion rIL2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316: 898–905

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Branscheid, D., Pomer, S., Krysa, S., Vogt-Moykopf, I. (1994). Survival After Lung Surgery for Metastatic Renal Cancer. In: Staehler, G., Pomer, S. (eds) Contemporary Research on Renal Cell Carcinoma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78609-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78609-9_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78611-2

  • Online ISBN: 978-3-642-78609-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics